Paper Details

  1. Home
  2. Paper Details

Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats.

Author: LawsJames L, McTigueDana M, SauerbeckAndrew, SchonbergDavid L

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

Oral deferasirox, an iron chelator, showed modest improvements in hindlimb function (but not tissue sparing) in rats with spinal cord injury in some studies. However, longer treatments and higher doses led to no significant improvements and toxic side effects like anemia, suggesting it may not be the best treatment option for spinal cord injury.
Paper Details　
Original Abstract of the Article :
Excess iron accumulation within the spinal cord is thought to exacerbate tissue damage and limit functional recovery after traumatic spinal cord injury (SCI). An optimal treatment to reverse or prevent damage would be to deliver an iron chelator systemically. Thus, we tested oral delivery of deferas...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/23712107

データ提供：米国国立医学図書館（NLM）

Systemic Iron Chelation: A Limited Solution for Spinal Cord Injury Recovery

Traumatic spinal cord injury (SCI) is a devastating condition that often results in permanent neurological deficits. Excess iron accumulation within the spinal cord is believed to exacerbate tissue damage and limit functional recovery. This study investigates the potential of systemic iron chelation, using the drug deferasirox, as a treatment strategy for SCI in rats. While deferasirox effectively reduced systemic iron levels, its impact on functional recovery was limited, suggesting that systemic iron chelation may not be the optimal approach for minimizing iron-mediated pathology after SCI.

Exploring Alternative Strategies for SCI Recovery

The study's findings highlight the need for further research into alternative strategies for promoting functional recovery after SCI. While systemic iron chelation showed limited efficacy in this study, other approaches, such as targeted delivery of iron chelators directly to the spinal cord, may hold greater promise for improving outcomes. The findings underscore the complexity of SCI and the need for a multifaceted approach to treatment.

Understanding the Complexities of SCI

SCI is a complex condition that often requires a multidisciplinary approach to treatment. This study provides valuable insights into the potential role of iron chelation in SCI recovery, but it also emphasizes the need for a comprehensive understanding of the underlying mechanisms of injury and repair. It's important to be aware of the limitations of current treatment options and to explore innovative approaches that may hold greater promise for improving outcomes.

Dr. Camel's Conclusion

The desert of SCI is a vast and challenging terrain, filled with obstacles that can hinder functional recovery. This study explores the potential of systemic iron chelation as a treatment strategy, revealing its limited efficacy. It's like searching for a hidden oasis of healing – a place where we can find effective solutions to promote restoration and improve the lives of individuals with SCI. The quest for a cure continues, and we must continue to explore new paths and approaches.

Date :
  1. Date Completed 2013-11-27
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

23712107

DOI: Digital Object Identifier

NIHMS646945

Related Literature

Article Analysis
・Side Effects of deferasirox
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.